These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32761818)

  • 1. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010810. PubMed ID: 32761818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010810. PubMed ID: 28685500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Zeng Y; Zhou R; Duan X; Long D
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011907. PubMed ID: 27387850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
    Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009961. PubMed ID: 25922858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B.
    Athale AH; Marcucci M; Iorio A
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010561. PubMed ID: 24763974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
    Iorio A; Matino D; D'Amico R; Makris M
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
    Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010822. PubMed ID: 32342499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Remmington T; Smith S
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011907. PubMed ID: 34423414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010822. PubMed ID: 27996087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Neely JA; Kalipatnapu S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010822. PubMed ID: 25394678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor eradication with rituximab in haemophilia: where do we stand?
    Franchini M; Mannucci PM
    Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for adolescents with haemophilia and high titre inhibitors.
    Fox RA; Neufeld EJ; Bennett CM
    Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.